SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kalanie, H.
Right arrow Articles by Kalanie, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalanie, H.
Right arrow Articles by Kalanie, A. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Multiple sclerosis: report on 200 cases from Iran

Hossein Kalanie

Shahid Beheshtie University of Medical Sciences, Department of Neurology, Loghman Hospital, Kamalie Street, Tehran, Iran

Kurosh Gharagozli

Shahid Beheshtie University of Medical Sciences, Department of Neurology, Loghman Hospital, Kamalie Street, Tehran, Iran

Amir Reza Kalanie

University of Otago Medical School, Christchurch, New Zealand

C linical findings of 200 patients in Iran with definite multiple sclerosis (MS) according to Poser et al.’s criteria and positive findings on magnetic resonance imaging (MRI) have been reviewed. The clinical course was relapsing-remitting (RR) for 88%, primary progressive (PP) for 7% and secondary progressive (SP) for 5% of cases. The mean age of onset was 27±7.4 years for the whole group and 37.1±8.8 years for PPMS. The gender ratio was 2.5:1 female:male. Involvement of the pyramidal system was the most common mode of presentation. Five per cent of patients had positive family history for the disease, 14% of patients had benign MS and 12% with disease duration longer than five years had an Expanded Disability Status Scale-2. The optico-spinal form was not a common form of presentation in the group.

Key Words: Iran • multiple sclerosis

Multiple Sclerosis, Vol. 9, No. 1, 36-38 (2003)
DOI: 10.1191/1352458503ms887oa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
A.-L. Sayao, V. Devonshire, and H. Tremlett
Longitudinal follow-up of "benign" multiple sclerosis at 20 years
Neurology, February 13, 2007; 68(7): 496 - 500.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M Houshmand, M H Sanati, F Babrzadeh, A Ardalan, M Teimori, M Vakilian, M Akuchekian, D Farhud, and J Lotfi
Population screening for association of mitochondrial haplogroups BM, J, K and M with multiple sclerosis: interrelation between haplogroup J and MS in Persian patients
Multiple Sclerosis, December 1, 2005; 11(6): 728 - 730.
[Abstract] [PDF]



Advertisement